Skip to main content
. 2023 Apr 6;13(7):1362. doi: 10.3390/diagnostics13071362

Table 3.

Univariate and multivariate Cox proportional hazard regressions on chitotriosidase activity (nmol/mL/h) and neopterin levels (nmol/L) at presentation, adjusted for TNM stage and neoadjuvant chemotherapy.

HR Unadjusted (95% CI) p HR Adjusted * (95% CI) p
Neopterin (nmol/L) 1.002 (0.9659–1.04) 0.9 1.0012 (0.952–1.0523) 0.96
Chitotriosidase (nmol/mL/h) 1.001 (0.9988–1.003) 0.37 1.0038 (1.00023–1.007) 0.03
Neopterin ≥ median 0.62 (0.267–1.48) 0.29 0.52 (0.18–1.46) 0.22
Chitotriosidase ≥ median 1.038 (0.43–2.507) 0.99 3.101 (0.758–12.69) 0.11

HR—hazard ratio; 95% CI—95% confidence interval; * Adjusted for TNM stage (I + II, III, and IV) and neoadjuvant chemotherapy.